Skip to content

corneal crosslinking in keratoconus patients

Continuous-light versus pulsed-light accelerated corneal crosslinking with ultraviolet-A and riboflavin in keratoconus patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190508043529N1
Enrollment
124
Registered
2019-08-15
Start date
2019-06-21
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus. Keratoconus

Interventions

Intervention 1: Intervention group 1: (continuous-light accelerated CXL group)
Accelerated CXL with continuous-light using 9 mW/cm2 for 10 minutes . Intervention 2: Intervention group 2: (pulsed-light accelerated CXL group)
Accelerated CXL with pulsed on/off light using 9 mW/cm2 for 10 minutes.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 30 Years

Inclusion criteria

Inclusion criteria: Progressive keratoconus (Progression of the disease was considered as confirmed if the loss of corrected distance visual acuity (CDVA) was more than one line in 1 year, or when the topographic keratometry increased by >1.0 D in 6 months or >2.0 D in 12 months) The thinnest central corneal thickness (CCT) >400 µm

Exclusion criteria

Exclusion criteria: Patients who wear contact lenses for one month prior to the initial evaluation and treatment Patients with immune system disorders Patients with corneal scar Patients with history of herpes simplex keratitis Patients who were pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
Best corrected spectacle visual acuity (BSCVA). Timepoint: 6 months after intervention. Method of measurement: E-chart.

Secondary

MeasureTime frame
Keratometric indices. Timepoint: 6 months after intervention. Method of measurement: Pentacam.;Biomechanical parameters. Timepoint: 6 months after intervention. Method of measurement: Corvis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Masihpour

Shiraz University of Medical Sciences

nasrin.masihpour@gmail.com+98 71 3629 1127

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026